Subsequently, CCK-8 assay revealed that SPARCL1 suppressed the proliferative ability of ESCC cells and counteracted the promoting effect of miRNA-105-5p on ESCC cell proliferation (Figure 4B). The gene discussed is SPARCL1; the disease is esophageal squamous cell carcinoma.